A5064964343- Epilepsy research and treatment
- Pharmacological Effects and Toxicity Studies
- SARS-CoV-2 and COVID-19 Research
- Peripheral Neuropathies and Disorders
- Autoimmune Neurological Disorders and Treatments
- Long-Term Effects of COVID-19
- Neuroscience and Neuropharmacology Research
- Genetics and Neurodevelopmental Disorders
- Electroconvulsive Therapy Studies
- Heparin-Induced Thrombocytopenia and Thrombosis
- Attention Deficit Hyperactivity Disorder
- Vaccine Coverage and Hesitancy
- Oral and gingival health research
- Psychology of Moral and Emotional Judgment
- Glycogen Storage Diseases and Myoclonus
- Cardiac electrophysiology and arrhythmias
- Bacterial Infections and Vaccines
- Genomics and Rare Diseases
- Psychosomatic Disorders and Their Treatments
- Family Caregiving in Mental Illness
- Cystic Fibrosis Research Advances
- Viral Infections and Immunology Research
- Bipolar Disorder and Treatment
- Retinal and Optic Conditions
- Cardiovascular Syncope and Autonomic Disorders
Instituto Nacional de Neurología y Neurocirugía
2013-2024
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
2022
Direccion General de Epidemiologia
2022
Secretaria de Salud
2022
National Hospital for Neurology and Neurosurgery
2022
University College London
2022
University of Southern Denmark
2022
University Medical Center Utrecht
2022
Heidelberg University
2022
University Hospital Heidelberg
2022
Aim There is a lack of studies related to the frequency, phenomenology, and associated features catatonic syndrome in patients with anti‐NMDA receptor encephalitis (ANMDARE). This study aimed measure frequency catatonia this condition delineate its particular symptoms. Methods A prospective was done all inpatients who fulfilled criteria definite ANMDARE admitted National Institute Neurology Neurosurgery Mexico from January 2014 September 2018. The Bush–Francis Catatonia Rating Scale Braünig...
Patients with anti-N-methyl-d-aspartate (NMDA) receptor encephalitis (ANMDARE) show a wide range of behavioral abnormalities and are often mistaken for primary psychiatric presentations. We aimed to determine the hallmarks ANMDARE use systematic neuropsychiatric cognitive assessments.A prospective study was conducted, 160 patients admitted National Institute Neurology Neurosurgery Mexico, who fulfilled criteria possible autoimmune and/or red flags along time window seven years. Cerebrospinal...
Information on stroke among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines remains scarce. We report incidence as an adverse event following immunization (AEFI) recipients of 79,399,446 doses 6 different SARS-CoV-2 (BNT162b2, ChAdOx1 nCov-19, Gam-COVID-Vac, CoronaVac, Ad5-nCoV, and Ad26.COV2-S) between December 24, 2020, August 31, 2021, in Mexico.This retrospective descriptive study analyzed per million hospitalized adult patients (≥18 years) during 8-month interval....
Information on Guillain-Barré syndrome (GBS) as an adverse event following immunization (AEFI) against SARS-CoV-2 remains scarce. We aimed to report GBS incidence AEFI among adult (≥18 years) recipients of 81,842,426 doses seven anti-SARS-CoV-2 vaccines between December 24, 2020, and October 29, 2021, in Mexico.Cases were retrospectively collected through passive epidemiological surveillance. The overall observed was calculated according the total number administered doses. Vaccines analyzed...
Abstract Introduction Epilepsy affects 65 million people worldwide, with a prevalence estimate in Mexico between 1 and 2% of the population. In 2006, estimated cost treatment for drug-resistant epilepsy was approximately USD 2646 per patient, increased expenses noted instances necessitating hospitalization. Methods We administered an internet survey disseminated through social networks, aimed at individuals (PWE) their caretakers residing Mexico. examined both direct indirect costs,...
To provide a comprehensive transnational overview of wait times for epilepsy surgery in Canada and Mexico.We reviewed all cases referred between 2007 2015 at the Saskatchewan Epilepsy Program Royal University Hospital (SEP) (n = 70; Saskatoon, Canada) National Institute Neurology Neurosurgery (NINN) 76; Mexico City, Mexico) compared times, calculated as time from diagnosis on assessment an center to surgery.Mean were similar across centers. Mean patient age was 37.4 ± 9 years 36.7 13.2...
The COVID-19 pandemic led to the development and emergency approval of an array effective vaccines against SARS-CoV-2. Given relatively small number patients included in vaccine trials, postapproval epidemiological surveillance is crucial detect infrequent vaccine-related adverse events. We conducted a nationwide retrospective descriptive study evaluating incidence seizures among recipients SARS-CoV-2 Mexico from December 24, 2020 (date administration first doses nationwide) October 29,...
Ictal bradycardia (IB) and ictal asystole (IA) are uncommonly recognized phenomena that increase morbidity in patients with epilepsy by causing syncope seizure-related falls. These arrhythmias also suspected to be involved the pathophysiology of sudden unexpected death (SUDEP). We report a case 57-year-old male left temporal lobe who experienced both IB IA. This patient was initially managed pacemaker implantation, prior undergoing lobectomy. Following surgery, had no ongoing or IA on his...
Background: The development of mRNA vaccines to prevent SARS-CoV-2 has been remarkably successful, with highly effective available less than one year after confirming the first case. Due global burden COVID-19 on health systems, emergency approval was attained clinical trials relatively small sample sizes and short follow-up periods. Limited information exists about incidence adverse events following immunisation (AEFI), particularly neurologic ones. Here, we describe AEFI reported by...
Drug-resistant epilepsy, a chronic condition with long-term consequences can be treated surgery. The efficacy and safety of surgery for temporal lobe epilepsy have been established through large number retrospective prospective cohort studies two randomized controlled clinical trials. Despite the excellent outcomes reported after surgery, literature suggests that this procedure is an underutilized treatment. While evidence lacking as to why underused, cited reasons include: failure primary...
<title>Abstract</title> <bold>Objective</bold> Corpus callosotomy (CC) is a commonly indicated palliative surgery for Drug-Resistant Epilepsy (DRE). While younger age at the time of well-established positive prognostic factor, there limited evidence on long-term outcomes in adult patients with DRE. A study that evaluates seizure control various follow-up points necessary to better understand CC.<bold>Methods</bold> In this retrospective longitudinal cohort we included CC operated by our...
Epileptic seizures are one of the main reasons for neurological visits in an emergency department. Convulsions represent a traumatic event patient and family, with significant medical social consequences. Due to their prevalence impact, initial management is vital importance. Although following first epileptic seizure, early recurrence diminishes after establishing treatment antiepileptic drugs, forecast developing epilepsy long-term outcomes not altered by any intervention. Detailed...
May 5, 2019April 9, 2019Free AccessEmployment and socioeconomic status after epilepsy surgery: A study in a Mexican cohort. (P1.5-011)Adib Jorge de Saráchaga, Gerardo Arellano-Flores, José Antonio Villar-Gallegos, Lyda V. Villamil-Osorio, Mario A. Alonso-Vanegas, Iris E. Martínez-Juárez, Laura Hernández-VanegasAuthors Info & AffiliationsApril 2019 issue92 (15_supplement)https://doi.org/10.1212/WNL.92.15_supplement.P1.5-011 Letters to the Editor
Summary Background Guillain-Barré syndrome (GBS) as an adverse event following immunization (AEFI) against SARS-CoV-2 has been linked to a few (ChAdOx1 nCov-19 and Ad26.COV2-S), but not all vaccines, including mRNA-based ones. Epidemiological information on GBS among recipients of other SARS-CoV-2-directed vaccines Latinx/Hispanic is scarce. Methods We report incidence per million administered doses from nationwide Mexican retrospective registry adult (≥18 years) 81,842,426 seven immunized...